Ipilimumab/nivolumabToxic epidermal necrolysis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1756卷 / 1期

关键词：

D O I：

10.1007/s40278-019-63080-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：201 / 201

相关论文

共 50 条

[1] Ipilimumab/nivolumabToxic epidermal necrolysis: case report
Reactions Weekly, 2021, 1848 (1) : 223 - 223
[2] Ipilimumab/nivolumabToxic epidermal necrolysis: case report
Reactions Weekly, 2023, 1947 (1) : 240 - 240
[3] NivolumabToxic epidermal necrolysis: case report
Reactions Weekly, 2016, 1612 (1) : 141 - 141
[4] NivolumabToxic epidermal necrolysis: case report
Reactions Weekly, 2025, 2053 (1) : 286 - 286
[5] Ipilimumab/Methylprednisolone/NivolumabToxic epidermal necrolysis and lack of efficacy
Reactions Weekly, 2024, 2006 (1) : 338 - 338
[6] Ipilimumab/nivolumabToxic epidermal necrolysis, thyroid dysfunction and fatal Stevens-Johnson syndrome: case report
Reactions Weekly, 2022, 1909 (1) : 300 - 300
[7] NivolumabToxic epidermal necrolysis and Stevens Johnson syndrome: case report
Reactions Weekly, 2021, 1854 (1) : 285 - 285
[8] NivolumabToxic epidermal necrolysis leading to sepsis and death: case report
Reactions Weekly, 2016, 1599 (1) : 170 - 170
[9] Ipilimumab/nivolumabMorbilliform erythematous eruption and pruritus progressed to toxic epidermal necrolysis: case report
Reactions Weekly, 2017, 1666 (1) : 165 - 165
[10] LevofloxacinToxic epidermal necrolysis: case report
Reactions Weekly, 2017, 1642 (1) : 182 - 182

← 1 2 3 4 5 →